Dupilumab, a simple pre-filled pen that people inject themselves with every two weeks, is the first biologic that targets both the symptoms of COPD and an underlying cause of the disease. It brings ...

NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...

NICE has approved the first targeted treatment for chronic obstructive pulmonary disease (COPD), offering a new option to up ...

Nearly 30,000 people in England living with chronic obstructive pulmonary disease could see their lives transformed after the ...

Please provide your email address to receive an email when new articles are posted on . Transplanting a patients’ own lung cells back into their lungs resulted in improved breathing. Lung damage was ...

Milan, Italy: For the first time, researchers have shown it is possible to repair damaged lung tissue in patients with chronic obstructive pulmonary disease (COPD) using the patients’ own lung cells.

We’ve all felt winded when taking the stairs or dealt with a cough from time to time. But if these issues linger, they could be early signs of chronic obstructive pulmonary disease (COPD). If you have ...

Credit: Getty Images. Ensifentrine is a first-in-class, dual phosphodiesterase 3 and 4 inhibitor. The Food and Drug Administration has accepted the New Drug Application for ensifentrine for the ...

WILMINGTON, Del.--(BUSINESS WIRE)--The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of ...